MoneyWorks4Me

Jagsonpal Pharmaceuticals informs about newspaper advertisement

28 Aug 2026 Evaluate
Pursuant to Regulation 30 and other applicable provisions of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, Jagsonpal Pharmaceuticals has informed that it enclosed the copy of newspaper advertisement published in newspapers, Business Standard (in English) and Business Standard (in Hindi) on August 28, 2026 regarding Notice of 47th Annual General Meeting of the Company sent to the members.

The above information is a part of company’s filings submitted to BSE.

Jagsonpal Pharma Share Price

243.00 0.40 (0.16%)
04-Sep-2026 14:57 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1901.00
Dr. Reddys Labs. 1157.40
Cipla 1380.45
Lupin 2106.55
Zydus Lifesciences 1126.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: